Mangompit, Bernie E.

HRN: 21-45-68  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2023
CEFUROXIME 750MG (VIAL)
10/10/2023
10/17/2023
IV
750mg
TID
Skin Tissue Infection

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines